New Enterprise Associates 17, L.P. is of Frequency Therapeutics, Inc.. Currently has a direct ownership of 1.09 Million shares of FREQ, which is worth approximately $0. The most recent transaction as insider was on Apr 22, 2024, when has been sold 17,857 shares (Common Stock) at a price of $56.0 per share, resulting in proceeds of $999,992. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.09M
0% 3M change
n/a 12M change
Total Value Held $0

New Enterprise Associates 17, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 22 2024
BUY
Open market or private purchase
$999,992 $56.0 p/Share
17,857 Added 1.61%
1,090,793 Common Stock

Also insider at

GLUE
Monte Rosa Therapeutics, Inc. Healthcare
BHG
Bright Health Group Inc. Healthcare
MBX
MBX Biosciences, Inc.
NEA

New Enterprise Associates 17, L.P.

Timonium, MD

Track Institutional and Insider Activities on FREQ

Follow Frequency Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FREQ shares.

Notify only if

Insider Trading

Get notified when an Frequency Therapeutics, Inc. insider buys or sells FREQ shares.

Notify only if

News

Receive news related to Frequency Therapeutics, Inc.

Track Activities on FREQ